HROW

Harrow Health News

FREE HROW REPORT

Company Name Stock Ticker Symbol Market Type
Harrow Health Inc HROW NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 14.47 04:00:04
Open Price Low Price High Price Close Price Prev Close
14.47
more quote information »

Recent News

Date Time Source Heading
1/26/20237:21IHNWFeaturedUCASU jump-starts its plan of NASDAQ or NYSE up-listing in 2023
1/23/202307:21EDGARCurrent Report Filing (8-k)
1/23/202307:00BWHarrow Closes Acquisition of U.S. Rights to ILEVRO®,..
1/20/202317:01EDGARAmended Statement of Ownership (sc 13g/a)
1/05/202307:00BWHarrow Announces Availability of Fortisite™ Formulations for..
12/23/202207:04EDGARStatement of Changes in Beneficial Ownership (4)
12/23/202207:03EDGARStatement of Changes in Beneficial Ownership (4)
12/23/202207:02EDGARStatement of Changes in Beneficial Ownership (4)
12/23/202207:01EDGARStatement of Changes in Beneficial Ownership (4)
12/21/202209:21BWMelt Pharmaceuticals’ MELT-300 (Midazolam 3mg and Ketamine..
12/21/202206:04EDGARCertification by the Exchange Approving Securities for..
12/20/202216:46EDGARCurrent Report Filing (8-k)
12/19/202216:51EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
12/16/202207:00BWHarrow Secures Capital to Close Recently Announced..
12/14/202207:28DJNHarrow Health to Buy U.S. Rights to Novartis Drugs For Up to..
12/14/202206:49EDGARCurrent Report Filing (8-k)
12/14/202206:46EDGARCurrent Report Filing (8-k)
12/14/202206:44EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
12/14/202206:32BWHarrow Announces Proposed Offering of $100 Million of Senior..
12/14/202206:31BWHarrow Prices $25 Million Offering
12/14/202206:30BWHarrow Enters into Agreement to Acquire Exclusive U.S...
11/30/202208:00BWHarrow and iOR Partners Expand National Product Supply..
11/14/202216:49EDGARQuarterly Report (10-q)
11/14/202216:41EDGARCurrent Report Filing (8-k)
11/14/202216:05BWHarrow Announces Third Quarter 2022 Financial Results
11/10/202208:00BWHarrow Launches Atropine.com
10/28/202208:00BWHarrow to Announce Third Quarter 2022 Financial Results on..
10/27/202208:00BWMelt Pharmaceuticals Announces Dosing of Last Patient in..
10/06/202210:05TRMNB.Riley Financial Sticks to Their Buy Rating for Harrow..
10/05/202217:35BWHarrow Sells Non-Ophthalmic Compounding Business
10/05/202217:28EDGARCurrent Report Filing (8-k)
10/03/202218:03EDGARStatement of Changes in Beneficial Ownership (4)
9/30/202206:16EDGARStatement of Changes in Beneficial Ownership (4)
9/29/202207:00BWImprimisRx Launches Fortisite™ (Tobramycin 1.5% + Vancomycin..
9/27/202216:55TRMNB.Riley Financial Remains a Buy on Harrow Health (HROW)
9/27/202215:28TRMNWhy Harrow Health Stock (NASDAQ:HROW) Soared Today
9/27/202213:50BWHarrow Announces U.S. FDA Approval of IHEEZO™..
9/22/202207:45EDGARCurrent Report Filing (8-k)
9/07/202213:15TRMNHarrow Health (HROW) Receives a New Rating from B.Riley..
8/11/202208:00BWHarrow Health to Participate in H.C. Wainwright 2nd Annual..
8/09/202216:37EDGARQuarterly Report (10-q)
8/09/202216:18EDGARCurrent Report Filing (8-k)
8/09/202216:01BWHarrow Health Announces Second Quarter 2022 Financial..
7/27/202207:00BWHarrow Health to Announce Second Quarter 2022 Financial..
6/24/202208:00BWHarrow Health Announces Launch of IOPIDINE® 1% and MAXITROL®..
6/13/202216:37EDGARCurrent Report Filing (8-k)
6/10/202218:05EDGARStatement of Changes in Beneficial Ownership (4)
6/10/202218:00EDGARStatement of Changes in Beneficial Ownership (4)
6/10/202217:56EDGARStatement of Changes in Beneficial Ownership (4)
6/07/202206:04EDGARNotice of Effectiveness (effect)
5/26/202217:11EDGARSecurities Registration Statement (simplified Form) (s-3)